Study on immune persistence of the CTN-1V strain rabies vaccine in humans

This study is a single-arm, single-center phase IV clinical trial on a rabies vaccine that has been marketed in China. The Vero cells and CTN-1V strain are used in the rabies vaccine product. The purpose of this study was to investigate the safety, immunogenicity and immune persistence of this produ...

Full description

Bibliographic Details
Main Authors: Lidong Wang, Jia Li, Qiuyue Mu, Lei Zhu, Yunpeng Wang, Ying Sheng, Danhua Zhao, Guoling Yang, Xiaoqing Yu, Xiaohong Wu, Li Miao
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Journal of Virus Eradication
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664024000025